Rheumatology NewsTrial shows olokizumab’s effect in nonresponders to TNF inhibitors in RASeptember 28, 2022Rheumatoid Arthritis
Tapering methotrexate and sustaining remission in RA: What are the chances?September 16, 2022Rheumatoid Arthritis
Comparative analysis of efficacies of different biological therapies for RA in the real worldSeptember 16, 2022Rheumatoid Arthritis
Lower risk for dementia among RA patients receiving b/tsDMARD vs csDMARDSeptember 16, 2022Rheumatoid Arthritis
Safety and efficacy of iguratimod as monotherapy or in combination with methotrexate in RASeptember 16, 2022Rheumatoid Arthritis
Real-world evidence on individual tapering of DMARD in patients with RASeptember 16, 2022Rheumatoid Arthritis
Faster treatment response with initial upadacitinib vs adalimumab in RASeptember 16, 2022Rheumatoid Arthritis
Risk factors for mortality in patients with RA-associated interstitial lung diseaseSeptember 16, 2022Rheumatoid Arthritis
Effect of rituximab dose on seroconversion after a third COVID-19 vaccineSeptember 16, 2022Rheumatoid Arthritis
Early RA: Sex difference in remission rates may be specific to interleukin-6 blockadeSeptember 16, 2022Rheumatoid Arthritis
Rheumatology NewsAutoimmune diseases linked to spike in post-MI eventsSeptember 15, 2022Lupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid Arthritis
Rheumatology NewsPossible sex differences found in response to first treatments for early RASeptember 13, 2022Rheumatoid Arthritis
Commentary: Early Intervention and Pregnancy Concerns in RA, September 2022August 31, 2022Rheumatoid Arthritis
